Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership Genetics Investing
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting Genetics Investing
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States Genetics Investing
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test Genetics Investing
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025 Genetics Investing
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome Genetics Investing
BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal Biotech Investing
